Purchase Order VA580W10126
Award Date 12/28/10
Potential Completion Date 1/28/11
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Scottsdale, AZ 85257, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the provision of the Provant Therapy System by Regenesis Biomedical Inc. to the Department of Veterans Affairs (VA). The Provant Therapy System is a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract, valued at $10,067.09, is a firm fixed-price purchase order with no set-aside designation. Regenesis Biomedical Inc. acts as the prime contractor, providing the Provant Therapy System...
- The federal contract award summarized in the provided information was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company, for the procurement of the Provant Therapy System. The $4,820.98 firm-fixed-price purchase order contract was awarded on January 28, 2011, with a completion date of February 28, 2011. The contract does not appear to have any set-aside designation. The award indicates that Regenesis Biomedical provides its...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a medical technology company. The $7,055.10 firm-fixed-price purchase order is for the company's Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has no set-aside designation and was awarded on December 16, 2010, with a completion date of January 16, 2011. Regenesis Biomedical, the...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System, a noninvasive regenerative medicine product. The $4,820.98 firm-fixed-price purchase order contract was awarded on January 10, 2011, with a completion date of February 10, 2011. The contract was awarded under Regenesis Biomedical's General Services Administration (GSA) Schedule 65-II-A for...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company, for the provision of the Provant Therapy System and related rental services. The $4,820.98 firm fixed-price purchase order contract was awarded on April 21, 2011, with a completion date of May 21, 2011. The contract was issued against Regenesis Biomedical's existing GSA Schedule 65-II-A for medical equipment and supplies, and did not utilize any...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $3,645.14 firm fixed-price purchase order is for the Provant Therapy System, a noninvasive regenerative medicine product developed and patented by Regenesis Biomedical. The contract has an ultimate completion date of March 25, 2011. This award was made against Regenesis Biomedical's General Services Administration (GSA) Schedule 65-II-A...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 contract is for the Provant Therapy System, a noninvasive regenerative medicine product developed and patented by Regenesis Biomedical. The Provant Therapy System is indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of March 16, 2011. Regenesis...
- This federal contract award is for the Provant Therapy System, a proprietary medical device developed by Regenesis Biomedical Inc. The $7,203.90 firm fixed-price contract was awarded by the Department of Veterans Affairs (VA) through VA Integrated Service Network 17. The contract is for the supply and rental of the Provant Therapy System, which is indicated for the palliative treatment of post-operative pain and edema. The contract was awarded as a purchase order and is not associated with any...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company, for the Provant Therapy System. The $3,645.14 firm fixed-price purchase order was awarded on October 15, 2010, with a completion date of November 15, 2010. The contract was not set aside for any preferential contracting vehicle. Regenesis Biomedical provides the Provant Therapy System, a patented noninvasive regenerative medicine product, to the VA...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm-fixed-price purchase order is for the company's Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of May 8, 2011 and was awarded through Regenesis Biomedical's existing GSA Schedule...